Reuters logo
3 个月前
BRIEF-Aldeyra Therapeutics presents noninfectious anterior uveitis Phase 2 clinical trial data
2017年5月17日 / 中午12点21分 / 3 个月前

BRIEF-Aldeyra Therapeutics presents noninfectious anterior uveitis Phase 2 clinical trial data

May 17 (Reuters) - Aldeyra Therapeutics Inc

* Presents noninfectious anterior uveitis Phase 2 clinical trial data

* Aldeyra Therapeutics - data demonstrated ADX-102 activity comparable to standard-of-care topical ocular corticosteroids in reducing anterior chamber cell count

* Says unlike corticosteroid therapy, ADX-102 did not increase intraocular pressure

* Aldeyra Therapeutics - results from Phase 3 trial of topical ADX-102 in NAU expected to be announced in second half of 2018

* Aldeyra therapeutics - results from co's Phase 2A dry eye syndrome clinical trial, expected in Q3 of this year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below